|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | ERCC1 in platinum-based treatment of non-small cell lung cancer with special emphasis on carboplatin: a review of current literalure 显示文摘 | Vilmar A Sorensen J B | 2009 | Lung Cancer2009，64，2： | 1 |
| 2 | RT-PCR versus immunohistochemistry for correlation and quantifi- cation of ERCC1, BRCA1, TUBB3 and RRM1 in NSCLC 显示文摘 | Vilmar A Garcia Foncillas J Huarriz M | 2012 | Lung Cancer2012，75，3： | 1 |
| 3 | RT-PCR versus immunohistochemistry for correlation and quantification of ERCC1,BRCA1,TUBB3and RRM1in NSCLC显示文摘 | Vilmar A Garcia-Foncillas J Huarriz M | 2012 | Lung Cancer2012，75，3： | 1 |
| 4 | Excision repair cross-complementation group1(ERCC1)in platinum-based treatment of non-small cell lung cancerwith special emphasis on carboplatin:a review of current literature显示文摘 | Vilmar A Sorensen JB | 2009 | Lung Cancer2009，64，2： | 1 |
| 5 | RT-PcR-Versus im- munohistochemistry Forcor-relation and quantification of ERCC1, TUBB3 and RRM1 in NSCLC显示文摘 | Vilmar A Garcia-Fonciuas J Huarriz M | 2012 | Lung Cancer2012，75，3： | 1 |
| 6 | RT - PCR versus immunohistochemistry for correlation and quantification of ERCC1, TUBB3 AND RRM1 in NSCLC 显示文摘 | Vilmar A Garcia - Foncillas J Huarriz M | 2012 | Lung Cancer2012，75，2： | 1 |
| 7 | Customising chemotherapy in advanced non-small cell lung cancer: daily practice and perspectives 显示文摘 | Vilmar A C Sorensen J B | 2011 | Eur Respir Rev2011，20，119： | 1 |
| 8 | Excision repair cross-complementation group 1 (ERCC1) in platinum-based treatment of non-small cell lung cancer with special emphasis on carboplatin:A review of current literature显示文摘 | Vilmar A Sorensen JB | 2009 | Lung Cancer2009，64，2： | 1 |
| 9 | Excision repair cross-complement- ation group 1 ( ERCC1 ) in platinum-based treatment of non-small cell lung cancer with special emphasis on carboplatin : a review of current literature显示文摘 | VILMAR A SORENSEN J B | 2009 | Lung Cancer2009，64，2： | 1 |
| 10 | Customising chemotherapy in advanced nonsmall cell lung cancer: daily practice and perspectives显示文摘 | Vilmar A C Sorensen J B | 2011 | Eur Respir Rev2011，20，119： | 1 |
| 11 | Excision repair cross - complementation group I ( ERCC1 ) in platinum - based treatment of non small cell lung cancer with special emphasis on carboplatin : areview of current literature显示文摘 | Vilmar A Sorensen JB | 2009 | Lung Cancer2009，64，2： | 1 |
| 12 | Prospective ran- domized phase III trial of triplet chemotherapy with paclitaxel + gemcitabine + cisplatin compared to standard doublet chemotherapy with vinorelbine + cisplatin in advanced non -small cell lung cancer 显示文摘 | Sorensen J Hansen O Vilmar A | 2009 | J Clin Oncol2009，27，15： | 1 |
| 13 | RT-PCR versus immunohistochemistry for correlation and quantification of ERCC1, BRCA1, TUBB3 and RRM1 in NSCLC显示文摘 | VILMAR A GARCIA-FONCILLAS J HUARRIZ M | 2012 | Lung Cancer2012，75，3： | 1 |
| 14 | RT-PCR versus immu- nobistochemistry for correliation and quantification of ERCC1, BRCA1 ,TUBB3 and RRM1 in NSCLC 显示文摘 | Vilmar A Garcia-Foneilas J Huarriz M | 2012 | Lung Cancer2012，75，3： | 1 |
| 15 | Excision repair cross - complemen- ration group 1 (ERCC1) in platinum - based treatment of non-small celt lung cancer with special emphasis on carbo- platin: a review o{ current literature 显示文摘 | Vilmar A Srensen J B | 2009 | Lung Cancer2009，64，2： | 1 |
| 16 | Predictive impact of RRM1 protein expression on vinorelbine efficacy in NSCLC patients randomly assigned in a chemotherapy phase HI trial 显示文摘 | Vilmar A C Santoni-Rugiu E Sorensen J B | 2013 | Ann Oncol2013，4，2： | 1 |
| 17 | ERCC1 and histopalhology in advanced NS;LC patients randomized in a large multicenter phase 11显示文摘 | Vilmar A C Santoni - Rugiu E Sorensen J B | 2010 | Ann Oneol2010，21，9： | 1 |
| 18 | Adjuvant chemothera- py in elderly patients ( > or = 75 yr) completely resected for colon cancer stage m compared to younger patients: toxicity and prognosis 显示文摘 | Jensen SA Vilmar A S0rensen JB | 2006 | Med Oncol2006，23，4： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员